Quantbot Technologies LP Incyte Corp Transaction History

Quantbot Technologies LP

$2.88 Billion
Q1 2025

A detailed history of Quantbot Technologies LP transactions in Incyte Corp stock. As of the latest transaction made, Quantbot Technologies LP holds 9,120 shares of INCY stock, worth $613,228. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,120

Previous 76 11900.0%

Holding current value

$613,228

Previous $5,000 10940.0%

% of portfolio

0.02%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$60.0 - $75.26 $542,640 - $680,651	9,044 Added 11900.0%	9,120 $552,000
Q4 2024 Feb 11, 2025	SELL	$65.08 - $83.38 $349,739 - $448,084	-5,374 Reduced 98.61%	76 $5,000
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $390,646 - $467,508	-6,814 Reduced 55.56%	5,450 $360,000
Q2 2024 Aug 09, 2024	BUY	$51.18 - $63.75 $611,959 - $762,258	11,957 Added 3894.79%	12,264 $743,000
Q1 2024 May 06, 2024	SELL	$56.55 - $66.59 $18,548 - $21,841	-328 Reduced 51.65%	307 $17,000
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $159,140 - $195,843	-3,051 Reduced 82.77%	635 $39,000
Q3 2023 Nov 07, 2023	SELL	$57.77 - $65.93 $1.55 Million - $1.77 Million	-26,815 Reduced 87.92%	3,686 $212,000
Q2 2023 Aug 08, 2023	BUY	$60.95 - $75.51 $1.56 Million - $1.94 Million	25,645 Added 528.11%	30,501 $1.9 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $341,036 - $417,664	4,856 New	4,856 $350,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $41,658 - $50,297	-631 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $528,698 - $618,596	-8,347 Reduced 92.97%	631 $46,000
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $583,214 - $713,581	8,493 Added 1751.13%	8,978 $617,000
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $38,736 - $42,452	485 New	485 $40,000
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $258,696 - $342,001	-3,403 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $20,669 - $25,011	-256 Reduced 7.0%	3,403 $295,000
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $311,271 - $401,355	3,659 New	3,659 $328,000
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $133,524 - $196,074	-1,800 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $3.42 Million - $4.65 Million	-54,055 Reduced 96.78%	1,800 $131,000
Q4 2019 Feb 10, 2020	BUY	$73.04 - $95.72 $3.25 Million - $4.26 Million	44,499 Added 391.85%	55,855 $4.88 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $601,201 - $714,309	8,256 Added 266.32%	11,356 $842,000
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $42,788 - $51,623	582 Added 23.11%	3,100 $263,000
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $11,504 - $15,958	181 Added 7.74%	2,518 $216,000
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $2.15 Million - $2.57 Million	-36,753 Reduced 94.02%	2,337 $148,000
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $2.41 Million - $2.9 Million	39,090 New	39,090 $2.7 Million
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $70,829 - $97,752	-1,164 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$83.06 - $100.98 $88,209 - $107,240	1,062 Added 1041.18%	1,164 $96,000
Q4 2017 Feb 12, 2018	BUY	$93.56 - $116.6 $9,543 - $11,893	102	102 $9,000

Others Institutions Holding INCY

# of Institutions

695

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account

Quantbot Technologies LP Incyte Corp Transaction History